A randomised dose-ranging study of tiotropium Respimat® in children with symptomatic asthma despite inhaled corticosteroids.
about
Long-term safety of tiotropium delivered by Respimat® SoftMist™ Inhaler: patient selection and special considerationsTiotropium in asthma: what is the evidence and how does it fit in?Muscarinic antagonists in early stage clinical development for the treatment of asthma.The evidence on tiotropium bromide in asthma: from the rationale to the bedside.Clinical efficacy of tiotropium in children with asthma.The evolving role of tiotropium in asthma.Tiotropium Bromide in Children and Adolescents with Asthma.Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma.Efficacy and safety of tiotropium in school-age children with moderate to severe symptomatic asthma: A Systematic Review.Long-term treatment in pediatric asthma: an update on chemical pharmacotherapy.Treatment of allergic children - Where is the progress (for the practicing allergist)?Tiotropium in the add-on treatment of asthma in adults: clinical trial evidence and experience.Long-Acting Muscarinic Antagonists for Difficult-to-Treat Asthma: Emerging Evidence and Future Directions.Tiotropium for the treatment of asthma: a drug safety evaluation.Role of muscarinic antagonists in asthma therapy.A randomised controlled trial of tiotropium in adolescents with severe symptomatic asthmaErratum to: A randomised dose-ranging study of tiotropium Respimat® in children with symptomatic asthma despite inhaled corticosteroids.Tiotropium in asthma: back to the future of anticholinergic treatment.Efficacy and Safety of Tiotropium in Children and Adolescents.Targeting acetylcholine receptor M3 prevents the progression of airway hyperreactivity in a mouse model of childhood asthma.Tiotropium for the Treatment of Asthma: Patient Selection and Perspectives.
P2860
Q28067579-EBD6F6E2-7B41-4258-8032-57F52D65B687Q28067912-C4B3D567-CE91-477C-8273-616B721EF28FQ30396144-6B982066-4624-4EA4-A6A8-35636BCA5B7DQ33644971-A3EBD016-FA50-4FC8-97A4-ACB8E7CD5A8CQ36876493-49C0A7E6-9A1C-4BB8-9EF1-B0EFD3FA51CFQ38598940-8B9DD74E-875C-4EA8-8AE5-CEEB57FAF37AQ38624579-94C73F51-91AD-4883-8B18-7131D4DD57DEQ38662759-545E816A-B6C8-4BF4-B96E-0CFF9112A245Q38686571-A67378FF-DE1C-4350-BAC6-18C9EC0950D8Q38733745-BAE65A5B-4EF4-4BC8-9534-DC98268B46B2Q38809512-ECD26BB4-BF2D-4469-9993-33BDB0190518Q38822829-EB9BAD39-4EA0-4A3F-A344-C58240C2A66FQ38854619-5FE25119-19D0-42B3-877A-37F5D9D62D8AQ38859764-04B9D055-D18D-41C9-A72B-5651AC2B470FQ39111607-A81803CF-1E76-42DC-9B79-EDB889825447Q39218466-A2497914-238A-43EA-9693-E50B4F99EB5CQ43203598-72F8F1FD-B288-4F6F-A82A-52654C4C9D36Q47164061-7893C555-C89B-4B7B-B1B5-F4340966C7F9Q47554173-AA844F3E-D49D-4477-8A1B-12EBB351CD4BQ47861360-3B0547D9-A3E2-4960-A90C-6904EE2C8AF8Q55131618-C5A2F4E0-E7B4-4735-9FB5-1713C9E8D4E8
P2860
A randomised dose-ranging study of tiotropium Respimat® in children with symptomatic asthma despite inhaled corticosteroids.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
A randomised dose-ranging stud ...... spite inhaled corticosteroids.
@ast
A randomised dose-ranging stud ...... spite inhaled corticosteroids.
@en
type
label
A randomised dose-ranging stud ...... spite inhaled corticosteroids.
@ast
A randomised dose-ranging stud ...... spite inhaled corticosteroids.
@en
prefLabel
A randomised dose-ranging stud ...... spite inhaled corticosteroids.
@ast
A randomised dose-ranging stud ...... spite inhaled corticosteroids.
@en
P2093
P2860
P1433
P1476
A randomised dose-ranging stud ...... spite inhaled corticosteroids.
@en
P2093
Christian Vogelberg
Eckard Hamelmann
Michael Engel
Migle Leonaviciute-Klimantaviciene
Petra Moroni-Zentgraf
Ralf Sigmund
P2860
P2888
P356
10.1186/S12931-015-0175-9
P577
2015-02-07T00:00:00Z
P5875
P6179
1036681555